Trials / Unknown
UnknownNCT00168870
Study of Metastatic Ocular Melanoma
Randomized Phase II Study to Compare a Combination Therapy With Gemcitabine and Treosulfan Versus a Monotherapy as First-Line Chemotherapy for Patients With Metastatic Ocular Melanoma
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 48 (estimated)
- Sponsor
- Charite University, Berlin, Germany · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates treatment with combination versus monotherapy for patients with metastatic ocular melanoma.
Detailed description
Treatment of patients with metastatic ocular melanoma with combination chemotherapy Gemcitabine and Treosulfan versus monotherapy with Treosulfan as first-line chemotherapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Gemcitabine | |
| DRUG | Treosulfan |
Timeline
- Start date
- 2003-02-01
- First posted
- 2005-09-15
- Last updated
- 2007-08-31
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00168870. Inclusion in this directory is not an endorsement.